weillcornellgucancer.org
What’s Next for Cutting-Edge Bladder Cancer Treatment?
AN UPDATE ON ATEZOLIZUMAB, AN IMMUNOTHERAPY Dr. David Nanus, Chief of Hematology and Medical Oncology at Weill Cornell Medicine and NewYork-Prebysterian Hospital and genitourinary (GU) cancer exper…